Home > Advocacy > Regulatory and Public Meetings Home > Advocacy > Regulatory and Public Meetings Regulatory and Public Meetings Page ContentAABB participates in or hosts meetings in conjunction with the federal government and other organizations, to represent the interests of our members in the transfusion medicine and cellular therapies communities and the patients we serve. These web pages provide the details of specific meetings: Public Meetings and Workshops with linked presentations - NEWGovernment Advisory/Regulatory Meetings Advisory Committee on Blood and Tissue Safety and Availability Blood Products Advisory Committee Cellular, Tissue and Gene Therapies Advisory Committee FDA Liaison Meetings Blood and Blood Components Cellular TherapiesPublic Meetings of Interest Prior to 2014 Transmissible Spongiform Encephalopathies Advisory Committee Summary of AABB’s Public Workshop on TRALI Risk Reduction, 07/08/13 Public Conference – Secondary Bacterial Screening of Platelet Components, 07/17/12 International Consensus Conference on Risk-Based Decision-Making for Blood Safety, 10/26-10/28/10 Analysis Analysis of FDA Guidance Documents to Promote Transparency of Advisory CommitteesAnalysis of Draft Guidance on FDA Conflict of Interest Policy Quick Links Ask the FDA and CLIA TranscriptsRegulatory/Government Affairs